Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity
A. Travassos, S. Teixeira, and P. Ferreira Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity Ophthalmic Surg Lasers Imaging 38 2007 233 237
Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: A morphologic study
L. Kong, H.A. Mintz-Hittner, R.L. Penland, F.L. Kretzer, and P. Chévez-Barrios Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: A morphologic study Arch Ophthalmol 126 2008 1161 1163
Off-Label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity
G.A. Lalwani, A.M. Berrocal, and T.G. Murray Off-Label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity Retina 28 Suppl 3 2008 S13 S18
Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity
H. Quiroz-Mercado, M.A. Martinez-Castellanos, M.L. Hernandez-Rojas, N. Salazar-Teran, and R.V. Chan Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity Retina 28 Suppl 3 2008 S19 S25
Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone i or posterior zone II
H.A. Mintz-Hittner, and R.R. Kuffel Jr. Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II Retina 28 2008 831 838
Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity
S. Honda, H. Hirabayashi, Y. Tsukahara, and A. Negi acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity Graefes Arch Clin Exp Ophthalmol 246 2008 1061 1063